Typicality: | 0.354 |
Saliency: | 0.244 |
by novartis | 6 | other |
therapy → be marketed as → kymriah | 7 |
therapy → be named → kymriah | 5 |
negative | neutral | positive |
0.015 | 0.733 | 0.252 |
Raw frequency | 12 |
Normalized frequency | 0.244 |
Modifier score | 0.500 |
Perplexity | 64.232 |